Royalty Pharma Statements
RP
Data from Royalty Pharma`s earning releases including common size income statement and balance sheet.
Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.
Key Information:
Report currency:
USD - US dollar
Last reporting period:
30 Sep, 2024
Next reporting period:
29 Dec, 2024
Report frequency:
Quarterly
Earnings release date:
06 Nov, 2024
Expected release date:
13 Feb, 2025
Royalty Pharma Income Statement
B
M
USD (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
564.69
5.1 %
100
—
0
—
—
0
0.5
0.09
56.72
10
-170.38
-163.7 %
-30.2
735.07
172.6 %
130.2
72.938
12.9
-1.654
-0.3
806.36
314.8 %
142.8
—
0
543.99
433.3 %
96.3
0.91
592.73
537.27
-5.4 %
100
—
0
—
—
0
0.5
0.09
54.708
10.2
267.64
-58.3 %
49.8
269.63
465.5 %
50.2
-81.253
-15.1
6
1.1
194.38
4649 %
36.2
—
0
102
2034.9 %
19
0.17
596.91
567.98
-4.7 %
100
—
0
—
—
0
0.5
0.09
57.652
10.2
641.75
3913.6 %
113
-73.774
-112 %
-13
73.186
12.9
-3.685
-0.6
-4.273
-100.6 %
-0.8
—
0
4.778
-99 %
0.8
0.011
597.48
596.07
11.1 %
100
—
0
—
—
0
0.5
0.08
59.185
9.9
-16.828
-104.4 %
-2.8
612.9
304.8 %
102.8
123
20.6
-18.308
-3.07
717.59
487.7 %
120.4
—
0
494.34
585.6 %
82.9
0.82
597.45
536.3
-0.4 %
100
—
0
—
—
0
50.5
9.4
57.2
10.7
384.9
33 %
71.8
151.4
-39.1 %
28.2
-27.7
-5.2
-1.7
-0.3
122.1
-65.2 %
22.8
—
0
72.1
-68.3 %
13.4
0.11
601.1
538.2
-21.3 %
100
—
0
—
—
0
0.5
0.09
47.6
8.8
289.4
41.2 %
53.8
248.8
-48.1 %
46.2
101.4
18.8
1.1
0.2
351.3
-31 %
65.3
—
0
227.6
-33.2 %
42.3
0.37
605.9
684
20.9 %
100
—
0
—
—
0
0.5
0.07
85.7
12.5
205
-52.6 %
30
479
259.9 %
70
32.9
4.8
-2.8
-0.4
509.1
183.5 %
74.4
—
0
340.8
174.7 %
49.8
0.56
607.3
565.7
-1.4 %
100
—
0
—
—
0
50.5
8.9
73.2
12.9
432.6
13.5 %
76.5
133.1
-30.7 %
23.5
-126.2
-22.3
-1.2
-0.2
-610
-376.8 %
-107.8
—
0
-456.1
-419.6 %
-80.6
-1.03
442.2
573.5
7 %
100
—
0
—
—
0
25.5
4.4
50.7
8.8
381.3
141 %
66.5
192.2
-49.1 %
33.5
39
6.8
-10.8
-1.9
220.4
-55.2 %
38.4
—
0
142.7
-53.1 %
24.9
0.23
607.2
536
-4.6 %
100
—
0
—
—
0
0.6
0.1
51.8
9.7
158.2
-53.8 %
29.5
377.8
72 %
70.5
114.8
21.4
-1
-0.2
491.6
283.8 %
91.7
—
0
304.5
487.8 %
56.8
0.5
607.2
562
-2.4 %
100
—
0
—
—
0
100.5
17.9
51.5
9.2
342.3
-18.9 %
60.9
219.7
43.2 %
39.1
-89.9
-16
-1.8
-0.3
128.1
138.5 %
22.8
—
0
51.8
555.7 %
9.2
0.08
607.2
575.7
-1.7 %
100
—
0
—
—
0
103.8
18
46.2
8
422.3
49.4 %
73.4
153.4
-49.4 %
26.6
-94.9
-16.5
-4.8
-0.8
53.7
-75.8 %
9.3
—
0
7.9
-92.2 %
1.4
0.02
431.4
585.8
5.5 %
100
—
0
—
—
0
90.5
15.4
48.6
8.3
282.7
248.8 %
48.3
303.1
-59.3 %
51.7
-80.5
-13.7
-0.8
-0.1
221.8
-72.5 %
37.9
—
0
101.9
-76.9 %
17.4
0.16
607.2
555
-3.1 %
100
—
0
—
—
0
3.1
0.6
44.9
8.1
-190
-155.3 %
-34.2
744.9
224.9 %
134.2
61.9
11.2
-0.1
-0.02
806.8
407.4 %
145.4
—
0
440.8
537.9 %
79.4
0.72
607.2
573
0.2 %
100
—
0
—
—
0
2.6
0.5
43.2
7.5
343.7
78.1 %
60
229.3
-39.5 %
40
-70.4
-12.3
—
0
159
-56.6 %
27.7
—
0
69.1
-59.6 %
12.1
0.11
607.1
572.1
6.3 %
100
—
0
—
—
0
7.8
1.4
50.1
8.8
193
594.2 %
33.7
379.2
-25.7 %
66.3
56.4
9.9
1.6
0.3
366.6
-41.3 %
64.1
—
0
171.1
-41.1 %
29.9
0.43
398.6
538.4
5.4 %
100
—
0
—
—
0
5.1
0.9
50.7
9.4
27.8
-72.6 %
5.2
510.6
24.7 %
94.8
137
25.4
1.8
0.3
624.3
3.7 %
116
—
0
290.6
767.5 %
54
0.79
370
510.9
2 %
100
—
0
—
—
0
5.8
1.1
42.8
8.4
101.6
-27.1 %
19.9
409.3
13.3 %
80.1
192.4
37.7
0.3
0.06
602
451.8 %
117.8
—
0
33.5
—
6.6
0.09
354
500.9
9.5 %
100
—
0
—
—
0
7.6
1.5
38.1
7.6
139.4
7.5 %
27.8
361.4
10.2 %
72.2
-246.4
-49.2
-5.9
-1.2
109.1
-39 %
21.8
—
0
—
-100 %
0
—
595.4
457.6
5.2 %
100
—
0
—
—
0
21.5
4.7
30.3
6.6
129.7
3142.5 %
28.3
327.9
-23.9 %
71.7
-149.1
-32.6
—
0
178.8
-54.9 %
39.1
—
0
151.7
-58.7 %
33.2
0.25
595.4
434.9
—
100
—
0
—
—
0
23
5.3
24.4
5.6
4
—
0.9
430.9
—
99.1
-34.9
-8.02
0.1
0.02
396.1
—
91.1
—
0
367.4
—
84.5
0.62
595.4